Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children’s Hospital of Philadelphia / Jenny Ruiz, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan / Challice Bonifant, MD, PhD |
Young Investigator Grants |
2015 |
Michigan |
Epigenetic regulation of self-renewal pathways in hematopoietic and leukemic stem cells |
George Washington University / Alexandros Tzatsos, MD/PhD |
Young Investigator Grants |
2012 |
District of Columbia |
Targeting Valine-Specific Amino Acid Dependency -in T-Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Palaniraja Thandapani, PhD |
Young Investigator Grants |
2019 |
New York |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Ex Vivo Modeling of Medulloblastoma using Human iPSC-Derived Cerebellar Organoids |
St. Jude Children’s Research Hospital / Stephanie Wu, PhD |
Young Investigator Grants |
2023 |
Tennessee |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma |
National Cancer Institute / Marielle Yohe, MD/PhD |
Young Investigator Grants |
2016 |
Maryland |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma |
University of California San Francisco / Elizabeth Young, MD |
Young Investigator Grants |
2021 |
California |
Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |